{
  "meta": {
    "title": "42_Nacp_Global_Initiatives",
    "url": "https://brainandscalpel.vercel.app/42-nacp-global-initiatives-3def3c35.html",
    "scrapedAt": "2025-11-30T18:15:12.632Z"
  },
  "questions": [
    {
      "text": "Which of the following is NOT a part of the target adopted by UNAIDS to end the AIDS epidemic?",
      "choices": [
        {
          "id": 0,
          "text": "95% of people living with HIV know their status."
        },
        {
          "id": 1,
          "text": "95% of people living with HIV receive antiretroviral therapy (ART)."
        },
        {
          "id": 2,
          "text": "95% of people receiving ART show decreased viral load."
        },
        {
          "id": 3,
          "text": "95% of people living with HIV have access to experimental treatments"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: D) 95% of people living with HIV have access to experimental treatments.</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>95% of people living with HIV to have access to experimental treatment is not a part of the targets adopted by UNAIDS.</p>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"102\" src=\"https://image.prepladder.com/content/zP4T9cz2OWGyqvS8fNwn1725454213.png\" width=\"257\" /></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:779px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Target & Goal for 2025 by UNAIDS</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"3\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>HIV Services</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>95-95-95 Testing and Treatment</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>95% know HIV status</li>\n\t\t\t\t<li>95% on <span class=\"customMeta\" data-dictid=\"4019cd26841692777181fa4c0c5a6a\">antiretroviral</span> therapy</li>\n\t\t\t\t<li>95% achieve <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> suppression</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Women of <span class=\"customMeta\" data-dictid=\"11e24b369816927771974383c7e17c\">Reproductive</span> Age</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>95% have HIV and sexual/reproductive health needs met,</li>\n\t\t\t\t<li>95% of pregnant/breastfeeding women achieve <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> suppression,</li>\n\t\t\t\t<li>95% of children tested</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>People at Risk of HIV</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>95% use suitable, prioritized, effective prevention options</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"9\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Integration</strong></p>\n\t\t\t</td>\n\t\t\t<td colspan=\"2\" rowspan=\"9\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>General Integration: Ensure 90% of individuals are <span class=\"customMeta\" data-dictid=\"8d0fca798b1692777191b6cd41880f\">linked</span> to services for communicable/non-communicable diseases, violence, and mental health.</li>\n\t\t\t\t<li>TB and HIV Services</li>\n\t\t\t\t<li>Maternal and Newborn Care</li>\n\t\t\t\t<li>HPV Vaccination: Ensure 90% of school-aged girls in priority countries receive HPV <span class=\"customMeta\" data-dictid=\"f23be6aa561692777201ca2e1aaa27\">vaccination</span> and <span class=\"customMeta\" data-dictid=\"26cdc047771692777198466c58cdc6\">schistosomiasis</span> screening/treatment.</li>\n\t\t\t\t<li>Sexual and <span class=\"customMeta\" data-dictid=\"11e24b369816927771974383c7e17c\">Reproductive</span> Health Services</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"6\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\"> \n\t\t\t<p><strong>Social Enablers</strong></p>\n\t\t\t</td>\n\t\t\t<td colspan=\"2\" rowspan=\"6\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>The 10-10-10 targets aim to eliminate social and legal barriers that hinder access to and <span class=\"customMeta\" data-dictid=\"6aee31718c16927772019237286270\">utilization</span> of HIV services.\n\t\t\t\t<ol>\n\t\t\t\t\t<li>Fewer than 10% of countries maintain punitive laws and policies restricting access to services.</li>\n\t\t\t\t\t<li>Fewer than 10% of people living with HIV and key populations face <span class=\"customMeta\" data-dictid=\"455ce1044b1692777199ef0d3f58ec\">stigma</span> and discrimination.</li>\n\t\t\t\t\t<li>Fewer than 10% of women, girls, people living with HIV, and key populations experience gender inequality and violence.</li>\n\t\t\t\t</ol>\n\t\t\t\t</li>\n\t\t\t\t<li>Achieve relevant SDG targets by 2030</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t\t<tr>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p><strong>Incorrect options</strong></p>\n\n<p><strong>95% of people living with HIV know their status</strong> <strong>(Option A): </strong>This is the first \"95\" of the 95-95-95 target. Goal: Ensure early diagnosis to initiate treatment and reduce transmission. This is a part of the UNAIDS target.</p>\n\n<p><strong>95% of people living with HIV receive <span class=\"customMeta\" data-dictid=\"4019cd26841692777181fa4c0c5a6a\">antiretroviral</span> therapy (ART)(Option B)</strong>: This is the <strong>second \"95\"</strong>. Once diagnosed, people should be promptly started on ART. <strong>This is a part of the UNAIDS target.</strong></p>\n\n<p><strong>95% of people receiving ART show decreased <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> load (Option C): </strong>This is the <strong>third \"95\". </strong>Goal: Achieve <strong>viral suppression</strong> to keep people healthy and prevent transmission. <strong>This is a part of the UNAIDS target.</strong></p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/zP4T9cz2OWGyqvS8fNwn1725454213.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/MclrWlNqNbKzh8DqlWcn1743154094.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/ZbZDTFUwSk6EuNzhl6lm1743154209.mp3"
    },
    {
      "text": "According to the Sustainable Development Goals (SDGs), the aim is to end the HIV/AIDS epidemic by what year?",
      "choices": [
        {
          "id": 0,
          "text": "2024"
        },
        {
          "id": 1,
          "text": "2025"
        },
        {
          "id": 2,
          "text": "2040"
        },
        {
          "id": 3,
          "text": "2030"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: D) 2030</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>According to the Sustainable Development Goals (SDGs), UNAIDS & UN aim to end the HIV/AIDS epidemic by 2030.</p>\n\n<p><strong>Sustainable Development Goal (SDG):</strong></p>\n\n<ul>\n\t<li>The Sustainable Development Goals (SDGs), adopted by the United Nations and UNDP in 2015, aim to eradicate poverty, ensure prosperity, and protect the planet by 2030.</li>\n\t<li>There are 17 goals, of which 1, 2, 3, 4, 5, 8, 10, 11, 16, and 17 are critical to <span class=\"customMeta\" data-dictid=\"7ae760ae1b169277718794068316b8\">ending</span> the HIV/AIDS epidemic by 2030.</li>\n</ul>\n\n<p style=\"text-align: center;\"></p>\n\n<p> </p>\n\n<p>India's National Strategic Plan for HIV/AIDS <span class=\"customMeta\" data-dictid=\"86c65ffa40169277718763f4072c2f\">elimination</span> aims for the year 2024. While this reflects a commitment to early action, it is not the global SDG target. <strong>(Option A)</strong></p>\n\n<p style=\"text-align: center;\"> </p>\n\n<p> \n<p> </p>\n</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/gNBx2VJQmKH0ksmq4rqK1743154595.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/tDv9ykrVRFrv03wIZsLM1743154671.mp3"
    },
    {
      "text": "By 2024, what percentage reduction in new HIV infections does the National Strategic Plan for HIV/AIDS in India aim to achieve, using a 2010 baseline?",
      "choices": [
        {
          "id": 0,
          "text": "75%"
        },
        {
          "id": 1,
          "text": "90%"
        },
        {
          "id": 2,
          "text": "80%"
        },
        {
          "id": 3,
          "text": "95%"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) 80%</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>The National Strategic Plan for HIV/AIDS in India aims to achieve an 80% reduction (using a 2010 baseline) in new <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infections by 2024.</p>\n\n<p> </p>\n\n<ul>\n\t<li>National Strategic Plan for HIV/AIDS and STIs 2017-2024 implemented in India aims to achieve an \"AIDS-free India\" by providing universal coverage of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> prevention, testing, and treatment.</li>\n\t<li>The plan sets a goal of <span class=\"customMeta\" data-dictid=\"116e588c7b1692777202c7f3040428\">zero</span> new infections, <span class=\"customMeta\" data-dictid=\"116e588c7b1692777202c7f3040428\">zero</span> AIDS-related deaths, and <span class=\"customMeta\" data-dictid=\"116e588c7b1692777202c7f3040428\">zero</span> AIDS-related <span class=\"customMeta\" data-dictid=\"455ce1044b1692777199ef0d3f58ec\">stigma</span> and discrimination.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>6 Key Objectives of the National Strategic Plan for HIV/AIDS in India (2017-2024):</strong></p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:744px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Target</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Timeline</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 1:</strong> Reduce new <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infections</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>80% reduction (using a 2010 baseline)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2024</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 2:</strong> Ensure people living with <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> (PLHIV) know their status</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>95% of estimated PLHIV know their <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> status</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2024</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 3: </strong>Ensure PLHIV have ART <span class=\"customMeta\" data-dictid=\"a4f93a26c11692777190f1659fa7c9\">initiation</span> and retention</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>95% of PLHIV have initiated and are retained on <span class=\"customMeta\" data-dictid=\"4019cd26841692777181fa4c0c5a6a\">antiretroviral</span> therapy (ART)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2024</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 4:</strong> Eliminate mother-to-child transmission</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Eliminate mother-to-child transmission of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> and syphilis</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2020</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 5: </strong>Eliminate HIV/AIDS-related <span class=\"customMeta\" data-dictid=\"455ce1044b1692777199ef0d3f58ec\">stigma</span> and discrimination</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Eliminate <span class=\"customMeta\" data-dictid=\"455ce1044b1692777199ef0d3f58ec\">stigma</span> and discrimination related to HIV/AIDS</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2020</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Objective 6: </strong>Facilitate sustainable NACP service delivery</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Ensure the National AIDS Control Programme (NACP) service delivery is sustainable</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>By 2024</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p>The plan also recognizes the different epidemiological contexts across states and union territories in India and emphasizes a tailored approach for each context:</p>\n\n<ol>\n\t<li><strong>Mature Epidemic</strong>: States/UTs with high <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> <span class=\"customMeta\" data-dictid=\"17cd3771bb1692777190950c142dbe\">incidence</span> and <span class=\"customMeta\" data-dictid=\"f86aae0bd61692777196f91458c9dd\">prevalence</span> in key, bridge, and other at-risk populations.</li>\n\t<li><strong>Emerging Epidemic</strong>: States/UTs with relatively new and rising infection rates among at-risk populations.</li>\n\t<li><strong>Low or Stable Epidemic</strong>: States/UTs with low infection rates require sustained focus to maintain low rates and eliminate transmission.</li>\n</ol>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/dzvp6YUGDumYKVoyVxkA1746565327.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/olp0DPNQv76GFw33QeTo1743156425.mp3"
    },
    {
      "text": "Which of the following types of surveillance is NOT used in India's National AIDS Control Programme to track and understand the HIV/AIDS epidemic?",
      "choices": [
        {
          "id": 0,
          "text": "Environmental Surveillance"
        },
        {
          "id": 1,
          "text": "Sentinel Surveillance"
        },
        {
          "id": 2,
          "text": "Behavioral Surveillance"
        },
        {
          "id": 3,
          "text": "Passive Surveillance"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: A) Environmental Surveillance</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>Environmental Surveillance is NOT typically used for HIV/AIDS. It focuses on monitoring factors in the environment that could influence disease transmission, which is not directly relevant to HIV/AIDS.</p>\n\n<p> </p>\n\n<p><strong>Types of surveillance activities used in India to detect the spread of HIV:</strong></p>\n\n<ul>\n\t<li>HIV <span class=\"customMeta\" data-dictid=\"f08132bdfb16927771986a66c5d7b6\">Sentinel</span> Surveillance</li>\n\t<li>HIV Sero-Surveillance</li>\n\t<li>AIDS Case Surveillance</li>\n\t<li>STD Surveillance</li>\n\t<li>Behavioral Surveillance</li>\n\t<li>Integration with Other Diseases</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/G5YgDbyWJ6YAYmXuWZQy1743156209.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/RjPVEvQQrUGx1J6xR9R51743156296.mp3"
    },
    {
      "text": "How frequently is Sentinel Surveillance for HIV conducted under the National AIDS Control Programme in India?",
      "choices": [
        {
          "id": 0,
          "text": "Annually"
        },
        {
          "id": 1,
          "text": "Biennial"
        },
        {
          "id": 2,
          "text": "Twice a year"
        },
        {
          "id": 3,
          "text": "Three times a year"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Biennial</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>HIV <span class=\"customMeta\" data-dictid=\"f08132bdfb16927771986a66c5d7b6\">sentinel</span> surveillance is conducted biennially, with the most recent surveillance in India done in 2021.</p>\n\n<p><strong>Sentinel Surveillance for HIV:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:715px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p><strong>HIV <span class=\"customMeta\" data-dictid=\"f08132bdfb16927771986a66c5d7b6\">Sentinel</span> Surveillance</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p>HIV <span class=\"customMeta\" data-dictid=\"f08132bdfb16927771986a66c5d7b6\">sentinel</span> surveillance tracks missing cases and monitors <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infection trends in specific groups and regions to understand epidemic dynamics and guide <span class=\"customMeta\" data-dictid=\"f42f73407916927771969cb688f953\">public health</span> interventions.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p><strong>Objectives</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Monitor <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infection trends & emerging pockets of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infection.</li>\n\t\t\t\t<li>Estimate <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> <span class=\"customMeta\" data-dictid=\"f86aae0bd61692777196f91458c9dd\">prevalence</span> in general population as well as high-risk groups and burden in the country and high-risk groups across states.</li>\n\t\t\t\t<li>Provide data for program evaluation and improvement.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p><strong>Key Features</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li><strong>Focus on High-Risk Groups: </strong>Commercial sex workers (CSW), <span class=\"customMeta\" data-dictid=\"e48bb8abfa1692777192e3fa06774f\">men</span> who have sex with <span class=\"customMeta\" data-dictid=\"e48bb8abfa1692777192e3fa06774f\">men</span> (MSM), injecting drug users, transgender individuals, single male migrants, and<strong> </strong>long-distance truck drivers.</li>\n\t\t\t\t<li><strong>Antenatal Women as Proxies: </strong>Includes data from <span class=\"customMeta\" data-dictid=\"42bfa0b99f16927771817ed9a23b27\">antenatal</span> women to estimate <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> <span class=\"customMeta\" data-dictid=\"f86aae0bd61692777196f91458c9dd\">prevalence</span> in the general population.</li>\n\t\t\t\t<li>Specific Sample Size:\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Total sample size in India(from the 2016-2017 study) is 900, divided among CSWs (250), MSMs (250), and <span class=\"customMeta\" data-dictid=\"42bfa0b99f16927771817ed9a23b27\">antenatal</span> women (400).</li>\n\t\t\t\t\t<li>Sample size from 2021 study - 400 <span class=\"customMeta\" data-dictid=\"42bfa0b99f16927771817ed9a23b27\">antenatal</span> women.</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p><strong>Key Uses</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Resource Allocation: Helps direct resources and interventions to the most affected areas and populations.</li>\n\t\t\t\t<li>Program Evaluation: Tracks trends to evaluate the effectiveness of HIV/AIDS control programs.</li>\n\t\t\t\t<li>Early Warning System: Acts as an early warning for emerging outbreaks or changes in transmission patterns.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p><strong>Frequency and Timing</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #333438; border-left:1px solid #333438; border-right:1px solid #333438; border-top:1px solid #333438; vertical-align:middle\">\n\t\t\t<p>Conducted biennially, with the most recent surveillance in India done in 2021</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/L0fnLAooyQRo8epml2gb1743156069.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/dpY3SsDYxHPyJgI2yP9d1743156131.mp3"
    },
    {
      "text": "Which of the following laboratory markers may be positive during the window period of HIV infection?",
      "choices": [
        {
          "id": 0,
          "text": "Gp41 antigen"
        },
        {
          "id": 1,
          "text": "P24 antigen"
        },
        {
          "id": 2,
          "text": "Beta-2 microglobulin (B2M)"
        },
        {
          "id": 3,
          "text": "Gp120 antigen"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) P24 antigen</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>P24 <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">antigen</span> is a laboratory marker that tests positive in the window period of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infection.</p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:714px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>LABORATORY DIAGNOSIS OF <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> INFECTION</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>Screening tests</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p>ELISA screens for <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> antibodies (most sensitive)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>Confirmatory tests</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Western <span class=\"customMeta\" data-dictid=\"2bc990c16116927771830255971ff6\">blot</span> - A confirmatory test confirms specific antibodies against p24 and gp41 proteins. (highly specific)</li>\n\t\t\t\t<li>Confirmatory test for adults - qPCR for HIV1</li>\n\t\t\t\t<li>Confirmatory tests of infants < 1 year - <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> DNA RT-PCR</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>Virus Isolation</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p>Direct virus testing is not standard; <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> isolation from cultured lymphocytes is costly and resource-intensive.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>CD4 <span class=\"customMeta\" data-dictid=\"c605d4126116927771916c2002638e\">Lymphocyte</span> Count</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p>Most reliable predictor of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> progression; absolute count indicates immune system health, with <200 cells/µL signalling a high risk of AIDS-related infections.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>CD4 <span class=\"customMeta\" data-dictid=\"c605d4126116927771916c2002638e\">Lymphocyte</span> Percentage</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p>Independent indicator of disease progression; <14% suggests a heightened risk of AIDS-related complications.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>HIV <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">Viral</span> Load Tests</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p>Measure actively replicating <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> in blood; correlate with disease <span class=\"customMeta\" data-dictid=\"3c305b384216927771969ca4166493\">progression</span> and assess <span class=\"customMeta\" data-dictid=\"4019cd26841692777181fa4c0c5a6a\">antiretroviral</span> therapy effectiveness.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<p><strong>Other Markers</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #272425; border-left:1px solid #272425; border-right:1px solid #272425; border-top:1px solid #272425; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Beta-2 <span class=\"customMeta\" data-dictid=\"06477fc93b16927771922ca7cd0afd\">microglobulin</span> (B2M) levels<strong> (Option C)</strong> and p24 <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">antigen</span> presence indicate immune <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> and <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> replication, aiding disease assessment.</li>\n\t\t\t\t<li>P24 <span class=\"customMeta\" data-dictid=\"782b31281a1692777181708484c1d1\">antigen</span> tests positive in the window period <strong>(Option B)</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/11yLDk1gIUvCuNqwhHxu1743155866.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/jj1NMNC9qcZkTLgRldDt1743155917.mp3"
    },
    {
      "text": "Match the following STI/RTI kits available at Suraksha clinics with their corresponding contents.\n\n\n\t\n\t\t\n\t\t\t\n\t\t\tKit Color\n\t\t\t\n\t\t\t\n\t\t\tContents\n\t\t\t\n\t\t\n\t\t\n\t\t\t\n\t\t\t1. Grey\n\t\t\t\n\t\t\t\n\t\t\tA. Genital ulcers\n\t\t\t\n\t\t\n\t\t\n\t\t\t\n\t\t\t2. Green\n\t\t\t\n\t\t\t\n\t\t\tB. Inguinal bubo\n\t\t\t\n\t\t\n\t\t\n\t\t\t\n\t\t\t3. White\n\t\t\t\n\t\t\t\n\t\t\tC. Urethral discharge, anorectal discharge, and cervicitis\n\t\t\t\n\t\t\n\t\t\n\t\t\t\n\t\t\t4. Yellow\n\t\t\t\n\t\t\t\n\t\t\tD. Lower abdominal pain\n\t\t\t\n\t\t\n\t\t\n\t\t\t\n\t\t\t5. Black\n\t\t\t\n\t\t\t\n\t\t\tE. Vaginitis",
      "choices": [
        {
          "id": 0,
          "text": "1-C, 2-E, 3-A, 4-D, 5-B"
        },
        {
          "id": 1,
          "text": "1-D, 2-A, 3-B, 4-C, 5-E"
        },
        {
          "id": 2,
          "text": "1-E, 2-D, 3-C, 4-B, 5-A"
        },
        {
          "id": 3,
          "text": "1-B, 2-C, 3-D, 4-A, 5-E"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: A) 1-C, 2-E, 3-A, 4-D, 5-B</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:638px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Suraksha Clinics: Integrating STI/RTI Treatment and HIV/AIDS Control</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Government STI/RTI clinics, branded as \"Suraksha Clinics,\" offer free standardized integrated <span class=\"customMeta\" data-dictid=\"cc122cedfb16927771990dec246d08\">STD</span> and RTI treatment services at district-level and above healthcare facilities.</li>\n\t\t\t\t<li>Under National AIDS Control Program (NACP)</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Referral Centers</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>STD Clinics at district, block, and First Referral Unit (FRU) levels act as referral centers for specialized treatment.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Counselling and <span class=\"customMeta\" data-dictid=\"672aab321d16927771840ecbc284dd\">Condom</span> Distribution</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Counselling services and high-quality condoms are provided to promote safer sexual practices.</li>\n\t\t\t\t<li>Utilizes the expertise of NGOs in providing counselling services at <span class=\"customMeta\" data-dictid=\"cc122cedfb16927771990dec246d08\">STD</span> clinics.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Training and strengthening existing centers</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Existing <span class=\"customMeta\" data-dictid=\"cc122cedfb16927771990dec246d08\">STD</span> clinics in hospitals and medical colleges are strengthened with technical support, equipment,</li>\n\t\t\t\t<li>Training for medical staff to manage STDs/RTIs using a <span class=\"customMeta\" data-dictid=\"87356352bc169277719923fcc93329\">syndromic</span> approach.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Pre-packed STI/RTI Color-Coded Kits</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<ul>\n\t\t\t\t<li>Free pre-packed kits provided to clinics, centrally procured and distributed through State AIDS Control Societies.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>Kit Colors and Conditions</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 1 (Grey)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Urethral discharge, <span class=\"customMeta\" data-dictid=\"a5d2b7108116927771811311422c5c\">anorectal</span> discharge, and cervicitis</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 2 (Green)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Vaginitis</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 3 (White)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Genital ulcers</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 4 (Blue)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Genital ulcers</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 5 (Red)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Genital ulcers</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 6 (Yellow)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Lower <span class=\"customMeta\" data-dictid=\"1665a40f1016927771801899eaed5d\">abdominal</span> pain</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Kit 7 (Black)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p>Inguinal bubo</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"187\" src=\"https://image.prepladder.com/content/PppM6pIuvVpigTGw99XH1725454855.png\" width=\"334\" /></p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/PppM6pIuvVpigTGw99XH1725454855.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/ndUKL8333jJAz4xxBfqW1746565386.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/OIejDoS5PsgMwSLAAuIA1746565499.mp3"
    },
    {
      "text": "Which of the following correctly describes the HIV diagnosis strategy for symptomatic and asymptomatic individuals?\n\nA. A single rapid test confirms HIV for both groups.\n\nB. Asymptomatic individuals need three reactive rapid tests at an SA-ICTC.\n\nC. Symptomatic individuals with discordant tests (1st +ve,2nd -ve) are retested after 14–28 days.\n\nD. Asymptomatic individuals with a reactive test are immediately considered HIV-positive.",
      "choices": [
        {
          "id": 0,
          "text": "A and C"
        },
        {
          "id": 1,
          "text": "B and D"
        },
        {
          "id": 2,
          "text": "B and C"
        },
        {
          "id": 3,
          "text": "A and B"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) B and C</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p><strong>Statement B:</strong> <span class=\"customMeta\" data-dictid=\"d1a9a79f701692777182066af09044\">Asymptomatic</span> individuals are tested with three rapid tests at an SA-ICTC, and a diagnosis is confirmed if all three tests are reactive.</p>\n\n<p><strong>Statement C:</strong> <span class=\"customMeta\" data-dictid=\"509310d4411692777199f2ffdb7769\">Symptomatic</span> individuals are retested after 14–28 days if the third test after a <span class=\"customMeta\" data-dictid=\"98d754de081692777186fc8119cb0c\">discordant</span> result (first reactive, second non-reactive) is also reactive.</p>\n\n<p><strong>Integrated Counselling and Testing Centres (ICTC)</strong>: These centres screen for <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> infection in multiple settings.</p>\n\n<p><strong>Types of ICTC:</strong></p>\n\n<ul>\n\t<li>Fixed ICTC: Standalone ICTC and Faculty ICTC</li>\n\t<li>Mobile ICTC</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:729px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Tests done in ICTC include:</strong></p>\n\n\t\t\t<ol>\n\t\t\t\t<li>ELISA (most sensitive)</li>\n\t\t\t\t<li>Rapid test or spot test</li>\n\t\t\t</ol>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Guidelines for ICTC:</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>For Blood transfusions</strong></p>\n\t\t\t<br />\n\t\t\t<br />\n\t\t\t<br />\n\t\t\t<br />\n\t\t\t<br />\n\t\t\t </td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"596\" src=\"https://image.prepladder.com/content/XXk04JkXJH7MooB779aD1725455571.jpg\" width=\"596\" /></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>For <span class=\"customMeta\" data-dictid=\"509310d4411692777199f2ffdb7769\">Symptomatic</span> patients</strong></p>\n\n\t\t\t<p><strong>(vs Statement A)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"1264\" src=\"https://image.prepladder.com/content/YchcF5CvWZWaSpIMxTOM1725455601.png\" width=\"349\" /></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n\t\t\t<p><strong>For <span class=\"customMeta\" data-dictid=\"d1a9a79f701692777182066af09044\">Asymptomatic</span> patients</strong></p>\n\n\t\t\t<p><strong>(vs Statement A&D)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"1184\" src=\"https://image.prepladder.com/content/u4MExUKgY7tmzXARYIeG1725455673.jpg\" width=\"392\" /></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/XXk04JkXJH7MooB779aD1725455571.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/qLGqzYefzF0qhGR1sZoU1743156563.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/wBJfn6MStSjNkzPnZ53a1743156785.mp3"
    },
    {
      "text": "A 32 Y/o woman presents to her primary care physician for a routine check-up. During the visit, the physician discusses various health screenings, including HIV testing. Which of the following testing strategies does HIV testing come under?",
      "choices": [
        {
          "id": 0,
          "text": "Opt-in testing."
        },
        {
          "id": 1,
          "text": "Opt-out testing."
        },
        {
          "id": 2,
          "text": "Both opt-in and opt-out testing."
        },
        {
          "id": 3,
          "text": "Compulsory testing"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Opt-out testing</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>\n\t<p><strong>HIV testing is recommended as <em>opt-out testing</em> in routine health care settings</strong>.</p>\n\t</li>\n\t<li>\n\t<p>Under this strategy, the patient is informed that HIV testing will be performed as part of routine tests unless they decline.</p>\n\t</li>\n\t<li>\n\t<p>This increases uptake, reduces stigma, and normalizes HIV testing.</p>\n\t</li>\n</ul>\n\n<p><strong>HIV Testing Strategies: </strong></p>\n\n<table>\n\t<thead>\n\t\t<tr>\n\t\t\t<th><strong>Strategy</strong></th>\n\t\t\t<th><strong>Description</strong></th>\n\t\t\t<th><strong>Used in</strong></th>\n\t\t</tr>\n\t</thead>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td><strong>Opt-in testing (Option A)</strong></td>\n\t\t\t<td>Patient is offered HIV test and must give explicit consent to be tested</td>\n\t\t\t<td>Common in older models and low-prevalence areas</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td><strong>Opt-out testing (Option B)</strong></td>\n\t\t\t<td>HIV testing is done as part of routine care unless the patient actively refuses</td>\n\t\t\t<td>Recommended by CDC, WHO for generalized testing</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td><strong>Compulsory testing (Option D)</strong></td>\n\t\t\t<td>HIV test is done without the patient’s consent or knowledge (e.g., blood donation screening)</td>\n\t\t\t<td>Used in select <span class=\"customMeta\" data-dictid=\"f42f73407916927771969cb688f953\">public health</span> or legal situations</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td><strong>Both opt-in and opt-out (Option C)</strong></td>\n\t\t\t<td>Not a formal strategy- rather a theoretical combination</td>\n\t\t\t<td>Not standardized or recommended together</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/sJAvMGx7rJptvOtBiUrD1743155322.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/z9vo9N47f0YLi0TmqaV91743155410.mp3"
    },
    {
      "text": "A 32 Y/o HIV-positive woman has just delivered a healthy baby girl. The mother has been on ART throughout her pregnancy and has maintained an undetectable viral load. Which of the following medications should the newborn be started on?",
      "choices": [
        {
          "id": 0,
          "text": "Zidovudine"
        },
        {
          "id": 1,
          "text": "Tenofovir"
        },
        {
          "id": 2,
          "text": "Nevirapine"
        },
        {
          "id": 3,
          "text": "Efavirenz"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) Nevirapine</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>Nevirapine is the drug that must be started for a <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">newborn</span> born to an HIV-positive mother on ART right from the beginning of pregnancy.</p>\n\n<p> </p>\n\n<p><strong>Prevention of Parent to Child Transmission of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> (PPTCT):</strong></p>\n\n<p>This programme was launched in the year 2002 to decrease the risk of transmission of <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> from pregnant women to infants.</p>\n\n<p> </p>\n\n<p><strong>Guideline for PPTCT:</strong></p>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"\" data-hash=\"\" data-license=\"\" data-source=\"\" data-tags=\"\" height=\"495\" src=\"https://image.prepladder.com/content/LOcXCioiYqiv2PQFKQ3a1725455934.jpg\" width=\"468\" /></p>\n\n<p><strong>Early infant diagnosis (EID): </strong></p>\n\n<ul>\n\t<li>HIV DNA RT-PCR is the IOC.</li>\n\t<li>If positive: ART is started immediately.</li>\n\t<li>If negative: Follow up every 6 months till 2 years of age.</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/LOcXCioiYqiv2PQFKQ3a1725455934.jpg"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/3bRPkqAlLv3C6w6hZhJ01743154988.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/lCDULycM0VMLSOBFzFIP1743155228.mp3"
    },
    {
      "text": "A 30 Y/o HIV-positive woman has just given birth to a healthy baby girl. She is currently on antiretroviral therapy (ART) and has maintained an undetectable viral load throughout her pregnancy. Which of the following advice is given by her healthcare provider on the breastfeeding protocol?",
      "choices": [
        {
          "id": 0,
          "text": "Breastfeeding is contraindicated as the risk of transmission is high."
        },
        {
          "id": 1,
          "text": "Breastfeeding is continued till 2 years of age if the newborn is positive for HIV."
        },
        {
          "id": 2,
          "text": "If the mother forgets to take ART, formula feeds can be given."
        },
        {
          "id": 3,
          "text": "Breastfeeding should only be initiated if the newborn is positive for HIV."
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) <span class=\"customMeta\" data-dictid=\"5af45ba59c16927771837f3aa7b6d9\">Breastfeeding</span> is continued till 2 years of age if the <span class=\"customMeta\" data-dictid=\"04df903fe8169277719383126b1b02\">newborn</span> is positive for HIV.</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p><strong>Breastfeeding protocol in <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> positive mother:</strong></p>\n\n<ul>\n\t<li>Exclusive <span class=\"customMeta\" data-dictid=\"5af45ba59c16927771837f3aa7b6d9\">breastfeeding</span> is recommended for the first six months for HIV-positive women.</li>\n\t<li>This applies whether the mother is on ART early or the infant receives ARV <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> for 6 weeks.</li>\n\t<li>After six months, introduce <span class=\"customMeta\" data-dictid=\"60d189ec981692777184053168bba4\">complementary</span> foods for other infants.</li>\n\t<li><strong>Avoid mixed <span class=\"customMeta\" data-dictid=\"11a5eea407169277720251b8446fa7\">feeding</span> at all costs</strong> (breast milk and other milk) during the first six months.</li>\n\t<li>If the infant tests HIV-negative, continue <span class=\"customMeta\" data-dictid=\"5af45ba59c16927771837f3aa7b6d9\">breastfeeding</span> until 12 months</li>\n\t<li>If the infant is HIV-positive, continue <span class=\"customMeta\" data-dictid=\"5af45ba59c16927771837f3aa7b6d9\">breastfeeding</span> until 2 years old.</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/4z2vsZ6oRU26GzH7NP4E1743154812.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/yPcWIcUaSXl6WtduEuBA1743154913.mp3"
    },
    {
      "text": "A 30 Y/o healthcare worker accidentally suffers a needlestick injury while drawing blood from a patient known to be HIV-positive. Which of the following medications should be immediately started for the healthcare worker?",
      "choices": [
        {
          "id": 0,
          "text": "Sulfamethoxazole + Trimethoprim"
        },
        {
          "id": 1,
          "text": "Isoniazid + Pyridoxine"
        },
        {
          "id": 2,
          "text": "Zidovudine"
        },
        {
          "id": 3,
          "text": "Tenofovir + Lamivudine + Dolutegravir"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: D) <span class=\"customMeta\" data-dictid=\"8ed4f962f416927772008ece0f551e\">Tenofovir</span> + <span class=\"customMeta\" data-dictid=\"548c02a1cf1692777191e70df694f8\">Lamivudine</span> + Dolutegravir</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<p><strong>Post-exposure <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> (PEP) for HIV:</strong></p>\n\n<ul>\n\t<li>PEP should be offered to individuals who may have been exposed to <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> through occupational exposure (e.g., healthcare workers) or sexual assault.</li>\n\t<li>The decision of whether or not to offer <span class=\"customMeta\" data-dictid=\"624ee3cb8d1692777195f4dce9b626\">PEP</span> is based on the type of exposure and the <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> status of the source.</li>\n\t<li>PEP should be started immediately after exposure, preferably within 72 hours.<br />\n\t </li>\n</ul>\n\n<p><strong>Treatment regimen:</strong></p>\n\n<ul>\n\t<li>Tenofovir + <span class=\"customMeta\" data-dictid=\"548c02a1cf1692777191e70df694f8\">Lamivudine</span> + <span class=\"customMeta\" data-dictid=\"ede6d62b71169277718679377f8c24\">Dolutegravir</span> <strong>(Option D)</strong></li>\n\t<li>Once daily for 28 days</li>\n\t<li>Best if initiated within 2 hours, but can be given up to 72 hours.</li>\n</ul>\n\n<p> </p>\n\n<p>Sulfamethoxazole + <span class=\"customMeta\" data-dictid=\"c207b9fd771692777200b0215ed212\">Trimethoprim</span> is given as <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> against <span class=\"customMeta\" data-dictid=\"5204097a961692777194904909b6fe\">opportunistic</span> infection in patients with CD4+ cells < 200. <strong>(Option A)</strong></p>\n\n<p>Isoniazid + <span class=\"customMeta\" data-dictid=\"cae8cdbe581692777196bd4dec479d\">Pyridoxine</span> is given as <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> against tuberculosis. <strong>(Option B)</strong></p>\n\n<p>Zidovudine, a NRTI, as a single agent, is not used for <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> against HIV. <strong>(Option C)</strong></p>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/GYKoVp82wlbHMl9NLT9M1747423020.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/rdGvXsYDyS1F0lvFJeX51747423077.mp3"
    }
  ]
}